Jonathan Solomon
Amministratore Delegato presso BIOMX INC.
Patrimonio netto: 8 400 $ in data 30/04/2024
Posizioni attive di Jonathan Solomon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOMX INC. | Direttore/Membro del Consiglio | 28/10/2019 | - |
| Amministratore Delegato | 28/10/2019 | - | |
Solomon Holdings Ltd.
 Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Direttore/Membro del Consiglio | 07/03/2013 | - |
| Presidente | 06/07/2010 | 07/03/2013 | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Direttore/Membro del Consiglio | 01/05/2017 | - |
| Amministratore Delegato | 01/05/2017 | - |
Storia della carriera di Jonathan Solomon
Precedenti posizioni note di Jonathan Solomon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/07/2006 | 05/03/2014 |
| Amministratore Delegato | 01/07/2006 | 01/12/2015 | |
| Fondatore | 01/07/2006 | 01/12/2015 | |
| Public Communications Contact | 01/07/2006 | 01/12/2015 | |
| Presidente | 01/07/2006 | 04/11/2014 | |
| Medtronic Corp. | Corporate Officer/Principal | - | - |
Formazione di Jonathan Solomon
| Tel-Aviv University | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Israele | 6 |
| Stati Uniti | 4 |
Posizioni
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| Chairman | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOMX INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Solomon Holdings Ltd.
Solomon Holdings Ltd. Real Estate DevelopmentFinance Solomon Holdings Ltd. engages in the provision of real estate services. It also initiates and executes residential construction projects, and invests in income-generating real estate properties. The company was founded on July 6, 1989 and is headquartered in Herzliya, Israel. | Finance |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
| Medtronic Corp. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
- Borsa valori
- Insiders
- Jonathan Solomon
- Esperienza